Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Joint association of patients’...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers

Bibliographic Details
Main Authors: Anlin Li, Yongjian Chen, Wenda Zhang, Haitao Zhong, Qiyun Ou, Yang Gu, Junqing Xia, Dagui Lin, Tuping Fu, Ruixin Liu, Hai Hu, Yunfang Yu, Herui Yao
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.92
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/ctm2.92

Similar Items

  • Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
    by: Zifan He, et al.
    Published: (2020-10-01)
  • Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
    by: Yunfang Yu, et al.
    Published: (2020-06-01)
  • Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
    by: Jared M. Newton, et al.
    Published: (2019-08-01)
  • ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
    by: Ruibin Yi, et al.
    Published: (2020-08-01)
  • Immune Checkpoint Inhibitors in Human Glioma Microenvironment
    by: Amina Ghouzlani, et al.
    Published: (2021-07-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...